mrc

+44 (0)20 7391 2700

Novel therapeutic
for spinal cord
injury


License Opportunity 270

Inhibition of Nogo signalling using a protein-based therapeutic
to promote neurite outgrowth and regeneration of the CNS

Novel protein-based therapeutic approach for spinal cord injury
using protein kinase A and/or casein kinase II

Use of protein to extracellularly phosphorylate the Nogo receptor to
alleviate inhibition of neurite growth

Demonstrated in vivo with restoration of mobility within 2 weeks

High un-met medical need for spinal cord injury therapeutics with
low μM detection limits

Please contact us to discuss this opportunity